Headquartered in Hyderabad, India, Granules offers collaborative and strategic partnership to global pharmaceutical leaders by producing best quality API, PFI and FD through …

We strive to provide access to safe, effective and affordable medicines to the people who need them. Here is how our key strengths help us achieve our objective.

In the API sector, Granules is among the largest manufacturers of first line of defence products (paracetamol, metformin, ibuprofen, guaifenesin & methocarbamol).

Granules India is led by a team of seasoned professionals of the pharmaceutical industry. Each leader brings in-depth expertise and a modern outlook to tackle the challenges of today’s …

Our Gagillapur unit is one of the largest single unit manufacturing site for PFIs and Finished Dosages which we are further adding to by increasing technology based capacities. In an …

2024, the hottest year on record, is a wake-up call for urgent climate action. Granules India is leading by example, embedding sustainability across operations—from pioneering green …

This acquisition strengthens Granules’ portfolio and opens up growth opportunities in the integrated Generics space in coming years. Granules will provide finished dosages of the new …

Granules India is a vertically integrated, high-growth pharmaceutical product manufacturing company based in Hyderabad, India. We manufacture high-quality API, FD, PFI and Speciality …

Over the past four decades, Granules India has emerged as a high-growth, vertically integrated pharmaceutical company with consistent performance and a growing global footprint.

Granules India is a vertically integrated, high-growth pharmaceutical product manufacturing company based in Hyderabad, India. We manufacture high-quality API, FD, PFI and Speciality …